申请人:Arena Pharmaceuticals, Inc.
公开号:EP2332919A2
公开(公告)日:2011-06-15
The present invention provides processes and intermediates for the preparation of 3-benzazepines and salts thereof which can be useful as serotonin (5-HT) receptor agonists for the treatment of, for example, central nervous system disorders such as obesity.
本发明提供了制备 3-苯并氮杂卓及其盐类的工艺和中间体,这些工艺和中间体可用作血清素(5-HT)受体激动剂,用于治疗肥胖等中枢神经系统疾病。